Clovis Oncology Earnings Date, Estimates & History (NASDAQ:CLVS)

Earnings

Clovis Oncology has confirmed that its next quarterly earnings report will be published on Monday, February 24th, 2020. Clovis Oncology will be holding an earnings conference call on Monday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Clovis Oncology Earnings Estimates and Actuals by Quarter

Clovis Oncology (NASDAQ:CLVS) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	2	($1.66)	($1.34)	($1.50)
Q2 2020	2	($1.61)	($1.11)	($1.36)
Q3 2020	2	($1.49)	($1.06)	($1.28)
Q4 2020	2	($1.34)	($1.03)	($1.19)
Q1 2021	2	($1.20)	($0.91)	($1.06)
Q2 2021	2	($1.16)	($0.88)	($1.02)
Q3 2021	2	($1.15)	($0.88)	($1.02)
Q4 2021	1	($0.78)	($0.78)	($0.78)

Clovis Oncology (NASDAQ CLVS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call	Details
2/24/2020 (Confirmed)		($1.64)					Register (After Market Closes)
11/7/2019	Q3	($1.89)	($1.72)	($2.06)	$35.84 million	$37.60 million	Transcript
8/1/2019	Q2 2019	($1.70)	($2.27)	($2.27)	$34.92 million	$32.98 million	N/A
5/7/2019	3/31/2019	($1.80)	($1.63)	($1.63)	$32.10 million	$33.12 million	N/A
2/26/2019	Q4 2018	($1.68)	($1.88)	($1.88)	$30.46 million	$30.40 million	Transcript
10/30/2018	9/30/2018	($1.60)	($1.71)	($1.71)	$30.11 million	$22.76 million	N/A
8/1/2018	Q2 2018	($1.38)	($1.94)	($1.94)	$22.44 million	$23.76 million	N/A
5/8/2018	Q1 2018	($1.36)	($1.54)	($1.54)	$18.34 million	$18.50 million	N/A
2/26/2018	Q4 2017	($1.29)	($1.04)	($1.50)	$19.42 million	$17.04 million	Transcript
11/1/2017	Q3 2017	($1.18)	($1.24)	($1.24)	$21.12 million	$16.81 million	N/A
8/2/2017	Q2 2017	($1.27)	($1.29)	$1.30	$13.07 million	$14.62 million	Listen
5/3/2017	Q1 2017	($1.43)	($1.33)	($1.33)	$6.04 million	$7.05 million	Listen
2/22/2017	Q416	($1.65)	($1.83)	($1.83)		$0.08 million	Listen
11/3/2016	Q316	($1.95)	($1.70)	($1.70)			Listen
8/8/2016	Q216	($2.13)	($2.07)	($0.77)			Listen
5/5/2016	Q116	($2.39)	($2.17)	($2.17)			Listen
2/25/2016	Q415	($2.39)	($2.23)	($1.34)			Listen
11/5/2015	Q315	($2.07)	($2.62)	($2.62)			Listen
8/6/2015	Q215	($2.11)	($2.10)	($2.10)	$1.17 million		Listen
5/6/2015	Q115	($1.78)	($1.86)	($1.86)	$13.60 million		Listen
2/25/2015	Q414	($1.41)	($1.62)	($1.62)			Listen
11/6/2014	Q314	($1.03)	($1.17)	($1.17)			Listen
8/7/2014	Q214	($0.93)	($1.03)	($1.03)		$13.60 million	Listen
5/8/2014	Q114	($0.85)	($0.91)	($0.91)		$13.60 million	Listen
2/27/2014	Q4 2013	($0.75)	($0.92)	($0.92)			Listen
10/31/2013	Q3 2013	($0.63)	($0.68)	($0.68)			Listen
8/1/2013	Q2 2013	($0.69)	($0.72)	($0.72)			Listen
5/7/2013	Q1 2013	($0.60)	($0.60)	($0.60)			Listen
2/28/2013	Q4 2012	($0.76)	($0.81)	($0.81)			N/A
11/5/2012	Q3 2012	($0.68)	($0.71)	($0.71)			N/A
8/8/2012	Q2 2012	($0.61)	($0.61)	($0.61)			N/A
5/8/2012	Q1 2012	($0.81)	($0.74)	($0.62)			N/A
3/7/2012	Q4 2011	($0.79)	($1.30)	($1.30)			N/A

(Earnings results data provided by Zacks Investment Research)